INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION

This adverse event was reported 48 times

These drugs are most commonly taken by patients reporting INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION:

# Drug Count
0 IOHEXOL 7
1 FEXOFENADINE 4
2 METHYLPHENIDATE HYDROCHLORIDE 4
3 BORTEZOMIB 3
4 GABAPENTIN 3
5 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 2
6 ESTRADIOL 2
7 ESTRADIOL GEL 0.1% 2
8 ESTRADIOL TRANSDERMAL 2
9 ESTRADIOL, 2
See all common drugs associated with INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION

INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FLUOROESTRADIOL F 18 2 0.0909
1 LIDOCAINE HCL AND MENTHOL 1 0.0074
2 PIFLUFOLASTAT F-18 1 0.0030
3 HYDROQUINONE 1 0.0017
4 IOHEXOL 7 0.0008
5 ERDAFITINIB 1 0.0008
6 ACARBOSE 1 0.0003
7 ZANUBRUTINIB 1 0.0002
8 LISDEXAMFETAMINE DIMESYLATE CAPSULES 1 0.0002
9 INCLISIRAN 1 0.0001
See all drugs enriched for association with INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION